News
7d
MarketBeat on MSNJNJ’s Stock Price Is Back in Rally Mode—The Time to Buy Is NowDetailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.
Johnson & Johnson's stock offers value with promising MedTech growth, raised guidance, strong dividends, and bullish ...
Zacks.com users have been paying close attention to Johnson & Johnson (JNJ). This makes it worthwhile to examine what the stock has in store.
2d
Zacks.com on MSNJohnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy?Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.
Shares of Johnson & Johnson broke out of a classic ascending triangle pattern. They have since stalled out at resistance.
Johnson & Johnson shares fell slightly Thursday after soaring yesterday amid investor optimism about the company's ...
Detailed price information for Teva Pharmaceutical Industries ADR (TEVA-N) from The Globe and Mail including charting and ...
As a baseline, the chance that JNJ will rise over any given week is 54.84%. Therefore, the statistical response to the 6-4-D sequence raises the odds considerably for the bullish speculator.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's an example: a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one with Style Scores of A and B, still has a downward-trending earnings outlook, and a bigger chance its share price ...
Johnson & Johnson (NYSE:JNJ) is one of the Most Undervalued High Quality Stocks to Buy According to Hedge Funds. On July 10, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results